Efficacy of Guselkumab in Treating Hailey Hailey Disease

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 13, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions

Hailey Hailey Disease

Interventions

DRUG

Guselkumab

Subcutaneous injection of 100 mg at Weeks 0, 4, 12, and 20

Trial Locations (1)

RECRUITING

Church Street Research Unit, Yale Center for Clinical Investigation, New Haven

All Listed Sponsors

collaborator

Janssen Scientific Affairs, LLC

INDUSTRY

lead

Yale University

OTHER